All News #Library
Others
Kytopen Boosts Commercialization And Board Post Series B
07 Apr 2026 //
PR NEWSWIRE
TQ Therapeutics Gmbh Partners Kytopen For Technology Access
02 Dec 2025 //
PR NEWSWIRE
Kytopen Names Michael Chiu CEO
08 Aug 2023 //
CONTRACT PHARMA
Kytopen Awarded NIH Grant to Unlock the Power of Engineered NK Cells
16 Jun 2021 //
BUSINESSWIRE

Market Place
Sourcing Support